390 likes | 564 Vues
HEART-LUNG TRANSPLANTATION. Overall. ISHLT. 2005. J Heart Lung Transplant 2005;24: 945-982. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR.
E N D
HEART-LUNG TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR NOTE: This figure includes only the heart-lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of heart-lung transplants worldwide has declined in recent years. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AVERAGE CENTER VOLUMEHeart-LungTransplants: January 1, 1998 - June 30, 2004 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
DISTRIBUTION OF HEART-LUNG TRANSPLANTS BY CENTER VOLUMEHeart-Lung Transplants: January 1, 1998 - June 30,2004 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
DISTRIBUTION OF HEART-LUNG TRANSPLANTS BY LUNG CENTER VOLUMELung Transplants: January 1, 1998 - June 30,2004 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival (Transplants: January 1982 - June 2003) Half-life = 2.9 years Conditional Half-life = 8.6 years N=3,080 N followed at longest time point: 1,899 Survival (%) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
HEART-LUNG TRANSPLANTATION Adult Recipients ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (1/1982-6/2004) “Other” includes cancer, LAM, OB, sarcoidosis, bronchiectasis ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS(Transplants: January 1982 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
1982-1995 1/1996-6/2004 DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA “Other” includes OB (non-ReTX), Bronchiectasis, Sarcoidosis ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG TRANSPLANTATIONIndications By Year (%) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG TRANSPLANTATIONIndications By Year (Number) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival for Adult Recipients(Transplants: January 1982 - June 2003) Half-life = 3.2 years Conditional Half-life = 9.0 years N=2,488 Survival (%) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTSFunctional Status of Surviving Recipients(Follow-ups: April 1994 – June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTSEmployment Status of Surviving Recipients(Follow-ups: April 1994 – June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTS: Rehospitalization Post-transplantof Surviving Recipients(Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between January 2001 through June 2004 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTSInduction Immunosuppression (Follow-ups: January 2000 - December 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between January 2001 through June 2004 NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression Drug Combinations at Time of Follow-upFor follow-ups between January 2001 through June 2004 NOTE: Different patients are analyzed in Year 1 and Year 5 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 1 Year Post-Transplant (Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
POST-HEART-LUNG TRANSPLANT MORBIDITY FOR ADULTSCumulative Prevalence in Survivors within 5 Years Post-Transplant (Follow-ups: April 1994 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from Coronary Artery Vasculopathy For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from Bronchiolitis Obliterans For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from Severe Renal Dysfunction*For Adult Heart-Lung Recipients(Follow-ups: April 1994-June 2004) *Severe renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Prevalence in Survivors(Follow-ups: April 1994-June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
Freedom from MalignancyFor Adult Heart-Lung Recipients(Follow-ups: April 1994- June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(Deaths: January 1992 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
HEART-LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNGRECIPIENTS (Transplants: January 1982 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTS(Transplants: January 1982 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Year of Transplant Number of Transplants NOTE: This figure includes only the heart transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as evidence that the number of pediatric heart-lung transplants worldwide has declined in recent years. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
“Other” includes Alpha-1, Bronchiectasis, IPF and OB (non-ReTX) DIAGNOSIS IN PEDIATRIC HEART –LUNG TRANSPLANT RECIPIENTS (Age: 11-17 Years) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC HEART-LUNG TRANSPLANTATIONKaplan-Meier Survival(Transplants: January 1982 - June 2003) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC HEART-LUNG TRANSPLANTATION Kaplan-Meier Survival by Era(Transplants: January 1982 - June 2003) Survival (%) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
PEDIATRIC HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(Deaths: January 1992 - June 2004) ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982